{"id":"placebo-to-loratadine","safety":{"commonSideEffects":[]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Placebo is an inert substance used as a control in clinical trials to establish the efficacy of loratadine through comparison. It contains no active pharmaceutical ingredient and produces no direct pharmacological effect beyond potential placebo response.","oneSentence":"This is a placebo control, not an active drug, and therefore has no pharmacological mechanism.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T00:01:30.840Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[]},"trialDetails":[{"nctId":"NCT05263206","phase":"PHASE3","title":"Efficacy and Safety of Subcutaneous Dupilumab for the Treatment of Adult Participants With Chronic Pruritus of Unknown Origin (CPUO) (LIBERTY-CPUO-CHIC)","status":"RECRUITING","sponsor":"Sanofi","startDate":"2022-02-15","conditions":"Pruritus","enrollment":284},{"nctId":"NCT01673620","phase":"PHASE3","title":"A Study to Evaluate the Safety of Combination Montelukast/Loratadine in Mexican Participants With Allergic Rhinitis (MK-0476A-484)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2012-07-04","conditions":"Allergic Rhinitis","enrollment":69},{"nctId":"NCT00423995","phase":"PHASE3","title":"Effect of Loratadine/Montelukast Combination on Congestion in SAR Patients Exposed to Pollen in an EEU (Study P04822)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2006-11-01","conditions":"Seasonal Allergic Rhinitis","enrollment":379},{"nctId":"NCT06396013","phase":"PHASE1","title":"A Multicentre Randomized Controlled Clinical Study on the Chitosan Nanocrystalline Qinteng Huoxue Runji Ointment Therapy for Psoriasis With Blood Stasis Syndrome.","status":"NOT_YET_RECRUITING","sponsor":"Beijing Hospital of Traditional Chinese Medicine","startDate":"2024-06-01","conditions":"Plaque Psoriasis","enrollment":96},{"nctId":"NCT06217367","phase":"PHASE4","title":"Over-the-Counter Antihistamines & Heat Stress","status":"UNKNOWN","sponsor":"Lakehead University","startDate":"2023-12-05","conditions":"Heat Illness, Allergic Rhinitis, Heat Injury","enrollment":16},{"nctId":"NCT05275933","phase":"PHASE2, PHASE3","title":"Efficacy of TCM Capsules Lian Hua Qing Wen Jiao Nang in Mild COVID-19 Patients","status":"COMPLETED","sponsor":"Singapore Chung Hwa Medical Institution","startDate":"2022-04-05","conditions":"COVID-19","enrollment":93},{"nctId":"NCT02495077","phase":"PHASE2","title":"Effects of Inhibiting Early Inflammation in Kidney Transplant Patients","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2015-11-02","conditions":"Kidney Transplant","enrollment":290},{"nctId":"NCT05265910","phase":"PHASE4","title":"A Study Comparing the Efficacy of Pataday® Once Daily Relief Extra Strength to Claritin® Tablets 24-Hour in Subjects With Allergic Conjunctivitis","status":"COMPLETED","sponsor":"Andover Research Eye Institute","startDate":"2021-12-14","conditions":"Allergic Conjunctivitis","enrollment":58},{"nctId":"NCT03004131","phase":"PHASE4","title":"MP-AzeFlu Allergen Chamber - Onset of Action Study","status":"COMPLETED","sponsor":"MEDA Pharma GmbH & Co. KG","startDate":"2017-01-07","conditions":"Seasonal Allergic Rhinitis","enrollment":82},{"nctId":"NCT05190627","phase":"PHASE2","title":"Effect of Loratadine in Lymphangioleiomyomatosis","status":"UNKNOWN","sponsor":"Institut d'Investigació Biomèdica de Bellvitge","startDate":"2021-11-01","conditions":"Lymphangioleiomyomatosis","enrollment":62},{"nctId":"NCT03443843","phase":"PHASE4","title":"A Study to Evaluate Changes in Nasal Airflow of Loratadine/Pseudoephedrine Tablet and Fluticasone Propionate Nasal Spray in Subjects Following Allergen Exposure","status":"COMPLETED","sponsor":"Bayer","startDate":"2018-02-21","conditions":"Rhinitis, Allergic","enrollment":82},{"nctId":"NCT02478398","phase":"PHASE3","title":"Efficacy and Safety Study of RAGWITEK™ (MK-3641) in Children With Ragweed-Induced Rhinoconjunctivitis With or Without Asthma (MK-3641-008)","status":"COMPLETED","sponsor":"Merck Sharp & Dohme LLC","startDate":"2015-07-20","conditions":"Rhinitis, Allergic, Seasonal","enrollment":1025},{"nctId":"NCT01700192","phase":"PHASE3","title":"Efficacy and Safety Study of SCH 900237/MK-8237 in Children and Adults With House Dust Mite-Induced Allergic Rhinitis/Rhinoconjunctivitis (P05607)","status":"COMPLETED","sponsor":"ALK-Abelló A/S","startDate":"2013-01","conditions":"Rhinitis, Allergic, Perennial, Rhinitis, Allergic, Nonseasonal","enrollment":1482},{"nctId":"NCT02932774","phase":"PHASE4","title":"Randomized, Double Blind, Parallel Group, Placebo Controlled, Multi-Center Study of the Efficacy and Safety of Cetirizine HCl Syrup vs. Loratadine Syrup vs. Placebo in Treatment of Children With Seasonal Allergic Rhinitis (SAR)","status":"COMPLETED","sponsor":"Johnson & Johnson Consumer and Personal Products Worldwide","startDate":"2001-03","conditions":"Allergic Rhinitis, Hay Fever, SAR","enrollment":683},{"nctId":"NCT00562159","phase":"PHASE3","title":"Efficacy and Safety of Grass Sublingual Tablet in Adults (P05238 AM3)(COMPLETED)","status":"COMPLETED","sponsor":"ALK-Abelló A/S","startDate":"2007-11","conditions":"Rhinoconjunctivitis, Rhinitis, Conjunctivitis","enrollment":439},{"nctId":"NCT00550550","phase":"PHASE3","title":"Efficacy and Safety of Grass Sublingual Tablet in Children and Adolescents (P05239 AM3)(COMPLETED)","status":"COMPLETED","sponsor":"ALK-Abelló A/S","startDate":"2007-11","conditions":"Rhinoconjunctivitis, Rhinitis, Conjunctivitis","enrollment":345},{"nctId":"NCT01228630","phase":"PHASE3","title":"Effectiveness of Two Preparations of Loratadine + Pseudoephedrine in Patients With Perennial Allergic Rhinitis.","status":"COMPLETED","sponsor":"Azidus Brasil","startDate":"2011-08","conditions":"Perennial Allergic Rhinitis","enrollment":156},{"nctId":"NCT02517957","phase":"PHASE2","title":"Xia Shi Surgical Treatment for Eczema Multi-center Clinical Research","status":"UNKNOWN","sponsor":"Shanghai Yueyang Integrated Medicine Hospital","startDate":"2015-08","conditions":"Eczema","enrollment":342},{"nctId":"NCT02007434","phase":"PHASE3","title":"Patient Experience Study of Deoxycholic Acid Injection","status":"COMPLETED","sponsor":"Kythera Biopharmaceuticals","startDate":"2013-12","conditions":"Moderate or Severe Submental Fullness","enrollment":84},{"nctId":"NCT01413958","phase":"PHASE3","title":"Effects of Phenylephrine Extended-Release Tablets on Allergy-Related Nasal Congestion (P08498 AM1)","status":"COMPLETED","sponsor":"Bayer","startDate":"2011-08","conditions":"Seasonal Allergic Rhinitis","enrollment":575},{"nctId":"NCT01469234","phase":"PHASE4","title":"A Study of Onset of Action of Loratadine and Fexofenadine in Participants With Seasonal Allergic Rhinitis (P08712)","status":"COMPLETED","sponsor":"Bayer","startDate":"2011-10","conditions":"Rhinitis","enrollment":255},{"nctId":"NCT01330017","phase":"PHASE2","title":"Effects of Phenylephrine on Nasal Congestion in Participants With Seasonal Allergic Rhinitis (P08156 AM2)(Completed)","status":"COMPLETED","sponsor":"Bayer","startDate":"2011-03","conditions":"Rhinitis, Seasonal Rhinitis","enrollment":539},{"nctId":"NCT00561717","phase":"PHASE4","title":"A Randomized, Placebo Controlled Study to Determine the Efficacy and Speed of a Nasal Spray in Allergen Induced Seasonal Allergic Rhinitis","status":"COMPLETED","sponsor":"Bayer","startDate":"2007-10","conditions":"Seasonal Allergic Rhinitis","enrollment":70},{"nctId":"NCT00449072","phase":"PHASE4","title":"Study of Triamcinolone Acetonide on the Growth Velocity of Children, Ages 3 to 9, With Perennial Allergic Rhinitis (PAR)","status":"COMPLETED","sponsor":"Sanofi","startDate":"2007-03","conditions":"Rhinitis, Allergic, Perennial","enrollment":299},{"nctId":"NCT01154153","phase":"PHASE4","title":"Nasacort AQ Hypothalamic-Pituitary-Adrenal (HPA) Axis Study in Children With Allergic Rhinitis","status":"COMPLETED","sponsor":"Sanofi","startDate":"2010-06","conditions":"Rhinitis, Allergic, Perennial and/or Seasonal","enrollment":140},{"nctId":"NCT00481676","phase":"PHASE2","title":"Efficacy and Safety of Omalizumab in Adults (18-70 Years) With Moderate to Severe Chronic Urticaria","status":"COMPLETED","sponsor":"Novartis","startDate":"2007-05","conditions":"Chronic Urticaria","enrollment":49},{"nctId":"NCT00796211","phase":"PHASE2","title":"A Single-Center Exploratory Study to Assess the Activity of CRx-197-002 in Plaque Psoriasis","status":"COMPLETED","sponsor":"Zalicus","startDate":"2008-11","conditions":"Plaque Psoriasis","enrollment":20}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"marketed","status":"active","brandName":"placebo to loratadine","genericName":"placebo to loratadine","companyName":"Bayer","companyId":"bayer","modality":"Small molecule","firstApprovalDate":"","aiSummary":"","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"partial","dataCompleteness":{"mechanism":true,"indications":false,"safety":false,"trials":true,"score":2}}